Sensyne Health (LON:SENS) Stock Price Down 33.3%

Sensyne Health PLC (LON:SENS) fell 33.3% on Tuesday . The stock traded as low as GBX 0.16 ($0.00) and last traded at GBX 0.35 ($0.00). 4,449,142 shares traded hands during trading, an increase of 29% from the average session volume of 3,449,819 shares. The stock had previously closed at GBX 0.53 ($0.01).

Sensyne Health Stock Down 33.3 %

The company has a current ratio of 2.26, a quick ratio of 2.26 and a debt-to-equity ratio of 6.02. The stock’s 50-day moving average price is GBX 0.35 and its 200-day moving average price is GBX 0.35. The company has a market cap of £582,624.00 and a P/E ratio of -0.02.

Sensyne Health Company Profile

Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts.